chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had upset stomach about 1 minute, then her throat felt like it was closing and it was hard to breathe. Called 911, then administered EPIPEN JR. She began to feel better, paramedics came quickly, took her to hosp.
Patient received vaccine 2/25/2017. Developed headache (R) arm pain within 12 hours. Over the next 24 hrs pt developed welts at the injection site; developed erythema and edema.
1 wk after vaccine-rash on chest 12 day after vaccine-general fatigue and muscle aches-rash.
-8/27/2020 @11:16 am, patient received ENGERIX B .Patient alert and verbally responsive. LN advised patient to remain seated in the chair in the immunization room to be monitored.   -@11:24 AM, LN noted patient remains sitting in chair,  alert and responsive but color is pale. CODE BLUE was paged overhead. Immunization staff continued to monitor patient.   -@11:24, multiple staff came in and helped assessed the patient. Put patient on lying position with both legs elevated. -@11:25 am, patient alert and verbally responsive. VS : BP 94/64, HR 60, 02 SAT RA 98%. Staff still continued to monitor the patient. Flight Sargent, was aslo assessing patient .   @11:31 am, patient alert and verbally responsive. Color is getting better.  VS : BP 109/73, HR 60, 02 SAT RA 98%. @11:35 am, patient alert and verbally responsive. No c/o difficulty breathing. Patient is no longer pale. No c/o pain. No chest pain.  VS : BP 104/68, HR 65, 02 SAT RA 100% @11:39 am, patient alert and verbally responsive. No difficulty breathing. No lightheadedness. No c/o pain.  Patient stated she is okay now and she's able to walk to the waiting area to be continued to be monitored for another 15 minutes. RN assisted the patient going to clinic. RN clinic is aware about what happened to the patient today.
Burning/ scalded tongue two weeks after second dose of vaccine.  At first I thought it was a sharp broken tooth. The dentist fixed what little bit he saw,  but the problem did not go away. I had my 6 month check up with the rheumatologist and he did not now what it was, so I went to my PCP, he treated me for thrush with Diflucan and a mouth rinse. Still, no relief. I went back to the dentist and he diagnosed me with burning tongue syndrome and gave me Kloonipin. I only took a quarter or half a pill once or twice a day, but it worked. Finally relief. But now the dentist wants someone else to figure it out, and the PCP doesn't know, the blood work came back fine. So I have tried acupuncture and L-lysine. Iron, and zinc. Basically if I just drink water, it's not too bad. But food and some scents seem to make it burn more. As well as stress.
he got the vaccine and went down too and now patient  walks in a cane; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (he got the vaccine and went down too and now patient  walks in a cane) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (he got the vaccine and went down too and now patient  walks in a cane). At the time of the report, VACCINATION COMPLICATION (he got the vaccine and went down too and now patient  walks in a cane) outcome was unknown.            Concomitant medication was not reported. Treatment information was not reported.   This case was linked to MOD-2021-425242 (Patient Link).   Reporter did not allow further contact
Patient received 1 dose of Moderna COVID-19 vaccine at age of 17 yrs
Patient had a vagal response caused by an anxiety attack due to fear of needles. Technician, gave the vaccine and then immediately called me in. The mother and son were worried about the needle disappearing due to the retraction mechanism. The son was loosing color in his face and becoming dizzy. I had him sit upright, talked with him for a few minutes, gave him Benadryl as a precaution, and checked his blood pressure. He was having no difficulty breathing and blood pressure was WNL. His mother said that he has passed out with needles before and that he had not eaten today. Eventually the patient claimed to lose his sight, and within 30s passed out. He was still sitting in the chair, bent over, vomited, and then immediately came back to consciousness. The patient then said that he felt fine and wanted to leave. I talked with him and his mother for around 20 minutes, had him eat a banana, and drink a full bottle of water. After the time, he felt fine and him and his mother left.
pain in left shoulder and arm;  limited range of motion, wake up at night with pain, needed help with ADLs  symptoms persisted requiring NSAIDs for over 6months
vaccination given 1 day past Beyond use date. Moderna ran stability report, vaccination was still safe and effective at time of vaccination.  No need to re-vaccinate. Pt had no adverse effects.
Tested very positive; Tested very positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and on 30Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 07Nov2022, outcome "recovered" (Nov2022) and all described as "Tested very positive". Due to his age 70 (no unit provided) and a medication, he could not stop he got IV mono-antibody. He had it bad (his O2 plunged to 88 on 07Nov2022 PM), the reporter had to give him albuterol treatment every 4 hours the night of the 7th. The patient was okay and negative now. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Nov2022) Positive; (Nov2022) Negative. Therapeutic measures were taken as a result of drug ineffective, COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201297436 same reporter/drug, different patient/event;
Weakness, SOB, chest pain, gastrointestinal issues; heart burn, headache, dizziness, and severe irritability.
This spontaneous report was received from a medical assistant regarding multiple unspecified patients with unknown demographics. Information on pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On unspecified dates, unspecified patients were administered with improperly stored M-M-R II, lot# M014902, expiry date: 22-MAR-2018 for prophylaxis (dosing details were not reported). Temperature was reported as 51.6 F and time frame was 2 hours 20 minutes. There was no previous temperature excursion. The call was due to data logger. No adverse effects were reported. No product quality complaint was involved. This is one of the several reports due to the same reporter. Additional information has been requested.
Patient vaccinated and complained initially of tingling sensation in fingertips at 1025.  Patient went to bathroom 10 minutes later.  At 1045 patient began complaining of coughing, throat was "tight", face was visibly flushed.  RN called Pharmacist requesting Benadryl.  Patient declined the liquid Benadryl offered by the pharmacist.  Patient had her own Benadryl 25 mg tablets in her car.  She agreed to take one 25 mg Benadryl po at 1050.  Patient normally takes 50 mg po every day and wanted to take another dose so she did at 1053.  Pulse was 60 and regular.  Patient did have relief of symptoms, decreased flushing, decreased throat tightness, and more calm after 30 minutes.  Patient agreed to wait awhile longer.  She was encouraged to follow up with her primary care doctor to discuss reactions and to determine how to proceed regarding getting a second dose of Pfizer vaccine.  At 1215 patient felt fine to drive home.  She was accompanied by her son.  RN to call patient later to see how she is feeling.
Within an hour of receving the vaccine, I became dizzy, had face tingling and arm tingling and felt mentally foggy.  As the day progressed, I felt a fullness in my throat and fatigue.  Over the next week, the dizziness became worse, I experienced intense headaches and shortness of breath for several days. I had difficulty sleeping and vivid dreams.  I have had thyroiditis twice in my life after giving birth to my 2 children with similar dizziness and throat fullness.  I decided to contact my doctors and had my thyroid levels checked.  My TSH was abnormal and my doctor thinks I could be having another episode of thyroiditis.  My menstrual cycle arrived a week early.  Following this, I continued to have dizziness, throat fullness, and intense headaches.  I developed sore breasts and breast discharge as well as in increase in frequency of urination.  I decided to postpone the second shot until I was feeling better as past episodes of thryoiditis took about 2 months to resolve.  My next menstrual period was a week late, also accompanied by mood swings, breast tenderness and intense headaches.  SIx weeks later, I continue to experience occasional dizziness and throat fullness and increased urination.  Prior to the vaccine, I was feeling fine and it seems like the vaccine triggered some kind of hormone/endocrine response in my body.  I have not had reactions to any vaccines prior to this.  I am quite hesitant to receive the second vaccine and am wondering if I should wait a period of time and try something  different such as the Johnson and Johnson one.  I? not quite sure what in the Pfizer vaccine ( perhaps the mRNA?) could have triggered this reaction in my thyroid and endocrine system. and would appreciate guidance on what to do next as I would like to be fully protected from COVID-19 but do not want to endure these unusual side effects.
swelling in the underarms, pain in breasts, masses found in breasts, peaked in march
Iridocyclitis; malaise; inflammation of eye; nausea; horrible headache; This spontaneous case was reported by a physician and describes the occurrence of IRIDOCYCLITIS (Iridocyclitis) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE and PRAVASTATIN for an unknown indication.   On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IRIDOCYCLITIS (Iridocyclitis) (seriousness criterion medically significant), MALAISE (malaise), EYE INFLAMMATION (inflammation of eye), NAUSEA (nausea) and HEADACHE (horrible headache). The patient was treated with GABAPENTIN for Adverse event, at an unspecified dose and frequency; IBUPROFEN for Adverse event, at an unspecified dose and frequency and PREDNISOLONE ACETATE (PRED FORTE) for Adverse event, at an unspecified dose and frequency. At the time of the report, IRIDOCYCLITIS (Iridocyclitis), MALAISE (malaise), EYE INFLAMMATION (inflammation of eye), NAUSEA (nausea) and HEADACHE (horrible headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On an unknown date lab data was performed CT Scan. The patient experienced eye pain as a result of iridocyclitis. Company Comment : This case concerns a 75-year-old, female patient with no medical history, who experienced the unexpected event of iridocyclitis along with other non serious events. The event occurred on an unknown date after the third dose of mRNA-1273. The rechallenge was not applicable, as events occurred after third dose and no further dosing was reported or planned, based on information provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a 75-year-old, female patient with no medical history, who experienced the unexpected event of iridocyclitis along with other non serious events. The event occurred on an unknown date after the third dose of mRNA-1273. The rechallenge was not applicable, as events occurred after third dose and no further dosing was reported or planned, based on information provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Spot where injection given feels as if indented in skin, grey, feels wierd, like my muscle tissue is dying.
Patient complained about coldness to her upper body and behind her neck as well as a funny taste in her mouth. She was released about 45 minutes later after she reported feeling much better but did have a dry mouth and funny taste still.
Mother advised patient told her yesterday (01-22-07) that he had hives on his legs and fever. He according to mother said been itchy for a few days. She believed he started itching either Friday PM or Saturday morning with fever. Gave him Benadryl yesterday for his complaint of itching.
Mom called on 2/24 and stated right leg swollen, red, with "krust" noted. Advised mom to apply cold compress to area. On 2/28/2000 presented with induration on right leg 23 x 23cm. No redness noted -infant does not appear to have pain or tenderness over induration. Mother very concerned and advised to see primary physician.
Muscle weakness/Tingling, weakness, and heaviness in my left arm and hand; Tingling in face and body/Tingling in my left arm and hand/Tingling and clinching in my jaw (both).; chills; some shortness of breath; some confusion; fatigue; heaviness in my left arm and hand.; clinching in my jaw (both); This is a spontaneous report from a contactable other healthcare professional (patient). A 46-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: ER2613, expiration date was not reported) via an unspecified route of administration, in left arm, on 17Mar2021 08:00 (at the age of 46-years-old), at dose 1, single for covid-19 immunization from hospital. Medical history included covid-19 on 21Jan2021 and continued with some long-haul symptoms since diagnosis (shortness of breath), acid reflux and constipation. Concomitant medications included azithromycin (Z-PAK); hydroxyzine hydrochloride (VISTARIL); fexofenadine hydrochloride (ALLEGRA); lansoprazole (PREVACID); bupropion hydrochloride (WELLBUTRIN); xylometazoline hydrochloride (NASAL SPRAY II). The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. The patient has not been tested with covid-19 since the vaccination. The patient experienced muscle weakness/weakness in left arm and hand, tingling in face and body/tingling in left arm and hand/tingling and clinching in jaw (both), chills, some shortness of breath, some confusion, fatigue and heaviness in left arm and hand on 17Mar2021 08:30. The reporter assessed the case as non-serious. No treatment was received for the events. The patient underwent lab tests and procedures which included covid-19: positive on 21Jan2021. The outcome of the events was recovering.  Follow-up #1 (27Mar2021): New information received from the same contactable other healthcare professional (patient) which includes: medical history details (shortness of breath, onset date for covid-19), concomitant drug details (Prevacid), reaction data (muscle weakness, some shortness of breath)  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient came into office to receive a Bivalent Booster dose for the COVID vaccine. Patient was administered a Pfizer Bivalent COVID vaccine for 6 month - 4 years of age dose. Patient was 6 years 1 month at the time of vaccination. The patient should have received a Pfizer Bivalent vaccine for 5 - 11 year old's due to age.
Shingrix187. 4 days after the injection, I developed a rash on my forehead.  No pain. No tingling. No itching. I called the drs office and I was able to talk to the Dr on call. We did a video call. He said it didn?t look like shingles but he could not rule it out. Since I didn?t have any other shingle symptoms, I waited. It did not go away. It only got worse.  On Monday, 06/22, I went to my dermatologist who visually confirmed the rash to be shingles.  I was prescribed Valtrex to stop further spreading of the blister like rash.  It is healing but I?ve had to call in sick at work and cancel my appointments this week.
This spontaneous report was received from a medical assistant and refers to a 19-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medications was provided. On an unspecified date in July 2014, he patient was vaccinated with the first dose of GARDASIL injection (dose, route of administration, lot# and expiration date were not reported). Then, on an unspecified date in August 2014, the patient received the second dose of GARDASIL injection (dose, route of administration, lot#. and expiration date were not reported). On 26-JUN-2017 (reported as today), the patient was vaccinated with a dose of GARDASIL 9 (lot # N003703, expiration date: 29-OCT-2017; dose and route of administration were not reported). That was the third dose of the human papillomavirus vaccine received by the patient. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Pt recvd vax 3AUG92 & approx 6 hrs following vax pt devel soreness lt arm & numbness & tingling in the lt side of body; also exp h/a & nausea for 3 days;
Oct 2 Smallpox vaccine. Lesions on hand 16 Oct. Generalized vaccinia 19 Oct.
During sleep time kept waking up and feeling like I was going to vomit.  Headache.
Moderna on 1/11 and 2/4. Positive on 8/11 admitted on 8/13-current
Within minutes of receiving Td, pt complained of nausea and itching.  Told no one. Day 2, complained of severe pain to left arm and neck.  States site was red, hard and hot to touch.  Day 3, pt went to ER and was seen in ER.  MD told her it was all due to TD injection. Pt complained of rash over entire body.
Client complains of light-headed.  Client positioned on the floor with legs elevated.  He complained of being warm.  Client eventually sat up and walked to waiting room.  Client and father remained in waiting room for approximately 30 minutes.  During that time he complained of itching at his shoulders.  No rash noted at chest or back.  His cheeks were flushed.  He complained that his throat was scratchy and his stomach hurt.  His temperature was 97 degrees, axillary, pulse 90 and regular.  His blood pressure was 124/80.
Swelling and pain at site, extreme pain and unable to raise left arm. Still have same symptoms now 11 days after injection. Using muscle cream, but not much help.
Upon waking up the next morning, the patient felt feverish. After taking several steps, a sudden bout of nauseousness came over them followed by lightheadedness, vision going black, and the patient fainting. This lightheadedness and fainting occurred again a few minutes later.
No adverse effects noted; a patient received improperly stored VARIVAX; This spontaneous report was received from a medical assistant referring to a male patient of unknown age. There was no information about the patient's concurrent conditions, drug reactions/allergies and medical history provided.  On 30-SEP-2019, the patient received improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S011951, expiration date was 16-APR-2019, but upon internal validation established as 16-APR-2021) (dose details and route of administration were not reported)for prophylaxis. The sterile diluent(lot #S015772, expiration date was 15-FEB-2022) used to reconstitute varicella virus vaccine live (oka/merck)(VARIVAX) was properly stored. The storage temperatures of the varicella virus vaccine live (oka/merck) (VARIVAX) was -12.3 degree Celsius for 6.05 hours. There were no previous temperature excursions. The temperature excursions were detected by a data logger. No adverse effects noted.   This is one of the seven reports received form the same reporter.; Sender's Comments:  US-009507513-1910USA007375: US-009507513-1910USA007348: US-009507513-1910USA007200: US-009507513-1910USA007189: US-009507513-1910USA007211: US-009507513-1910USA006992:
GF is positive after international travel together, PCR-19Apr inconclusive; Sore throat; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A 31-year-old male patient received BNT162b2 (BNT162B2), on 26Oct2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 30 years for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, Lot no.: EL3247), administration date: 27Jan2021, when the patient was 30-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 2, Lot no.: EL3247), administration date: 17Feb2021, when the patient was 30-year-old, for COVID-19 Immunization. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 19Apr2022, outcome "recovering", described as "Sore throat"; EXPOSURE TO SARS-COV-2 (non-serious), outcome "unknown", described as "GF is positive after international travel together, PCR-19Apr inconclusive". It was unknown if therapeutic measures were taken as a result of oropharyngeal pain.  Additional information: Unknown if covid prior vaccination and unknown if tested covid post vaccination.   No follow-up attempts are possible. No further information is expected.
pt recvd vax 18FEB93 & devel redness, inflammation, swelling, & warmth @ inject site; No further details were provided;
Narrative:  83 yo M with a history of Type 2 DM, diabetic peripheral neuropathy, HTN, hyperlipidemia, obesity, obstructive sleep apnea, hx of stroke with residual weakness of left arm/hand, GERD ,diverticulosis, hiatal hernia, chronic constipation, varicosities of legs, BPH, mild urinary incontinence, ED, gout, DJD, chronic knee pain, OA , spinal stenosis of L spine, depression, and history of smoking. Patient receive covid vaccinations on 2/8/21 and 3/11/21. Not much is known about patients death other than it occurred on 6/22/21. Patient had a upper endoscopy on 6/21/21 for dysphagia. Death seems to be unrelated to covid vaccinations.
Patient began feeling lightheaded and nausea, followed by intense sweating.  Small amount of vomit.  Proceeded to feel full body arthralgia, primarily acute in lower limbs.  Patient stated it was painful to walk.  She received some relief from ibuprofen and heat.  Continues to have bone pain below the waist on day follow up.  Refer to ER since clinic MD not available.
pt recv vax & devel soreness & swelling @ inj site,as well as diff breathing;no treatment was necessary;
Red, swollen with welt.  C/o headache & some nausea.  Went to ER 4/21/11 in AM they gave her antibiotic (KEFLEX) & mother has been using ice packs for comfort.  ER advised it was cellulitis.
pt exp severe joint stiffness & swelling w/limited mobility x 1 wk 24 hrs p/vax;
Patient stated that had earache Monday - Thursday after vaccine on Saturday. On Friday, woke up and right side of face frozen. Patient diagnosed it as Bells Palsy.
fell to the floor just finished giving the MMR; face & lips were very pale; twitching of the lt shoulder; was able to follow verbal commands;
FEVER 100.5 PAIN AND SWELLING TO  RIGHT AXILLA LYMPHNODES. SYMPTOMS BEGAN ON 06/12/2023 AFTER  VACCINE WAS ADMINISTERED.